Implementation of HIV and Tuberculosis Diagnostics: The Importance of Context

Clinical Infectious Diseases

Volumn 61, Issue , 2015, Pages S119-S125

  Dominique, Joyelle K ^a   Ortiz Osorno, Alberto A ^b,c   Fitzgibbon, Joseph ^c   Gnanashanmugam, Devasena ^d   Gilpin, Christopher ^e   Tucker, Timothy ^f   Peel, Sheila ^g   Peter, Trevor ^h   Kim, Peter ^d   Smith, Steven ⁱ  

^a Office of Science Management and Operations   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d Division of AIDS   (United States)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f Advisory and Development Consulting   (South Africa)

^g WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^h CLINTON HEALTH ACCESS INITIATIVE   (United States)

ⁱ NATIONAL DEPARTMENT OF HEALTH   (South Africa)

Author keywords

Diagnostics; diagnostics' implementation; HIV; point of care; tuberculosis

Indexed keywords

AFRICA SOUTH OF THE SAHARA; ARTICLE; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE PRACTICE; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL INFORMATION SYSTEM; POINT OF CARE TESTING; PRIORITY JOURNAL; TUBERCULOSIS; BENCHMARKING; HEALTH CARE DELIVERY; HIV INFECTIONS; LABORATORY; POINT OF CARE SYSTEM; SOUTH AFRICA;

BENCHMARKING; DELIVERY OF HEALTH CARE; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; LABORATORIES; POINT-OF-CARE SYSTEMS; SOUTH AFRICA; TUBERCULOSIS;

EID: 84943390334     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ552     Document Type: Article

References (46)

1. TDR Diagnostics Evaluation Expert Panel; Banoo S, Bell D, Bossuyt P, et al. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol 2010; 8(12 suppl):S17-29.
2. UNITAID. HIV/AIDS. Diagnostics technology landscape. 4th ed, 2014. Available at: http://www.unitaid.org/images/marketdynamics/publications/UNITAID-HIV-Diagnostic-Landscape-4th-edition.pdf. Accessed 7 May 2015.
3. UNITAID. Tuberculosis diagnostic. Technology and market landscape. Semi-annual update, 2013. Available at: http://www.unitaid.org/images/marketdynamics/publications/UNITAID-TB-Dx-Landscape-Update-Dec %202013.pdf. Accessed 7 May 2015.
4. National Academy of Sciences. Appendix A-learning what works best: the nation's need for evidence on comparative effectiveness in health care: an issue overview. Learning what works: infrastructure required for comparative effectiveness research, 2009. Available at: http://www.ncbi.nlm. nih.gov/books/NBK64787/pdf/TOC.pdf. Accessed 7 May 2015.
5. Larson BA, Schnippel K, Brennan A, et al. Same-day CD4 testing to improve uptake of HIV care and treatment in South Africa: point-of-care is not enough. AIDS Res Treat 2013; 2013:941493.
6. World Health Organization. Adapting WHO normative HIV guidelines for national programmes, 2011. Available at: http://whqlibdoc.who.int/publications/2011/9789241501828-eng.pdf. Accessed 7 May 2015.
7. Centers for Disease Control and Prevention. Guidelines for appropriate evaluations of HIV testing technologies in Africa, 2002. Available at: http://www.who.int/diagnostics
8. World Health Organization. Technical and operational considerations for implementing HIV viral load testing. Interim technical update, 2014. Available at: comment http://www.who.int/hiv/pub/arv/viralload-testing-technical-update/en/. Accessed 7 May 2015.
9. World Health Organization. TB diagnostics and laboratory services: information note, 2009. Available at: http://www.who.int/tb/dots/lab.pdf. Accessed 7 May 2015.
10. United Nations. Achieving the global public health agenda dialogues at the Economic and Social Council, 2009. Available at: http://www. un.org/en/ecosoc/docs/pdfs/achieving-global-public-health-agenda. pdf. Accessed 7 May 2015.
11. Peter TF, Shimada Y, Freeman RR, et al. The need for standardization in laboratory networks. Am J Clin Pathol 2009; 131:867-74.
12. Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the XpertMTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013; 13:349-61.
13. Caliendo AM, Gilbert DN, Ginocchio CC, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis 2013; 57(suppl 3):S139-70.
14. University of Pittsburgh Medical Center-Center for Health Security. Diagnosing infection at the point of care, 2013. Available at: http://www.upmchealthsecurity.org/our-work/pubs-archive/pubs-pdfs/2013/2013-08-28-diagnosing-infection-poc-REV.pdf. Accessed 7 May 2015.
15. World Health Organization. Partnering and public health practice. Experience of national TB partnerships, 2013. Available at: www.stoptb. org/assets/documents/countries/partnerships/stop-tb-layout-low-res-final.pdf. Accessed 7 May 2015.
16. Reyburn H, Mbakilwa H, Mwangi R, et al. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ 2007; 334:403.
17. World Health Organization. TB diagnostics and laboratory strengthening: WHO monitoring of Xpert MTB/RIF roll-out. TB Xpert Project. Available at: http://www.who.int/tb/laboratory/mtbrifrollout/en/. Accessed 7 May 2015.
18. Clouse K, Page-Shipp L, Dansey H, et al. Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level. S Afr Med J 2012; 102:805-7.
19. Martin R, Barnhart S. Global laboratory systems development: needs and approaches. Infect Dis Clin North Am 2011; 25:677-91, x.
20. Lucas H. Information and communications technology for future health systems in developing countries. Soc Sci Med 2008; 66:2122-32.
21. Yu D, Souteyrand Y, Banda MA, Kaufman J, Perriens JH. Investment in HIV/AIDS programs: does it help strengthen health systems in developing countries Global Health 2008; 4:8.
22. Larson BA, Brennan A, McNamara L, et al. Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bull World Health Organ 2010; 88:675-80.
23. Elbireer AM, Opio AA, Brough RL, Jackson JB, Manabe YC. Strengthening public laboratory service in sub-Saharan Africa: Uganda case study. Lab Medicine 2011; 42:719-25.
24. Alemnji G, Fonjungo P, Van Der Pol B, Peter T, Kantor R, Nkengasong J. The centrality of laboratory services in the HIV treatment and prevention cascade: the need for effective linkages and referrals in resource-limited settings. AIDS Patient Care STDS 2014; 28:268-73.
25. Peter TF, Rotz PD, Blair DH, et al. Impact of laboratory accreditation on patient care and the health system. Am J Clin Pathol 2010; 134:550-5.
26. Acuna-Villaorduna C, Vassall A, Henostroza G, et al. Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries. Clin Infect Dis 2008; 47:487-95.
27. Pho MT, Deo S, Palamountain KM, et al. Optimizing tuberculosis case detection through a novel diagnostic device placement model: the case of Uganda. PLoS One 2015; 10:e0122574.
28. Massambu C, Mwangi C. The Tanzania experience: clinical laboratory testing harmonization and equipment standardization at different levels of a tiered health laboratory system. Am J Clin Pathol 2009; 131:861-6.
29. Joloba ML. Activities of Uganda SRL, 2012. Available at: http://www. stoptb.org/wg/gli/assets/html/GLI5/Activities%20of%20Uganda% 20SRL.pdf. Accessed 11 May 2015.
30. Ministry of Health, Republic of Uganda. Three Uganda laboratories receive International Best Practice Awards: "Honourable Mention", in respect of their innovative Sample Transport System, 2015. Available at: http://health.go.ug/mohweb/node/139. Accessed 7 May 2015.
31. Siedner MJ, Haberer JE, Bwana MB, et al. High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study. BMC Med Inform Decis Mak 2012; 12:56.
32. Siedner MJ, Santorino D, Haberer JE, et al. Know your audience: predictors of success for a patient-centered texting app to augment linkage to HIV care in rural Uganda. J Med Internet Res 2015; 17:e78.
33. Estill J, Egger M, Blaser N, et al. Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study. AIDS 2013; 27:1483-92.
34. Hanrahan CF, Selibas K, Deery CB, et al. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care Xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa. PLoS One 2013; 8:e65421.
35. Van den Handel T, Hampton KH, Sanne I, et al. The impact of Xpert (R) MTB/RIF in sparsely populated rural settings. Int J Tuberc Lung Dis 2015; 19:392-8.
36. Dheda K, Theron G,Welte A. Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa. Lancet Glob Health 2014; 2:e554-6.
37. Theron G, Peter J, Dowdy D, et al. Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings Lancet Infect Dis 2014; 14:527-32.
38. Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 2014; 383:424-35.
39. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, 2013. Available at: http://www. who.int/hiv/pub/guidelines/keypopulations/en/. Accessed 7 May 2015.
40. Médecins Sans Frontières. MSF access campaign: putting HIV treatment to the test: a product guide for viral load and point-of-care CD4 diagnostic tools, 2013. Available at: https://www.msf.es/sites/default/files/publicacion/msf-informe-Putting-HIV-treatment-to-the-test.pdf. Accessed 7 May 2015.
41. Saha S, Beach MC, Cooper LA. Patient centeredness, cultural competence and healthcare quality. J Natl Med Assoc 2008; 100:1275-85.
42. Calmy A, Balestre E, Bonnet F, et al. Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings. BMC Infect Dis 2012; 12:147.
43. Doyle T, Smith C, Vitiello P, et al. Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis 2012; 54:724-32.
44. United Nations Joint Programme on HIV/AIDS. The Gap Report, 2013. Available at: http://www.unaids.org/sites/default/files/media-asset/UNAIDS-Gap-report-en.pdf. Accessed 7 May 2015.
45. World Health Organization. Global tuberculosis report, 2014. Available at: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809-eng. pdfua=1. Accessed 7 May 2015.
46. Voss De Lima Y, Evans D, Page-Shipp L, et al. Linkage to care and treatment for TB and HIV among people newly diagnosed with TB or HIVassociated TB at a large, inner city South African hospital. PLoS One 2013; 8:e49140.